Avzivi

Avzivi (Bevacizumab) is an intravenous medication used to treat certain types of cancer. This anti-angiogenic therapy helps inhibit tumor growth by targeting blood vessel formation.

Avzivi is primarily used in the treatment of various cancers, including colorectal, lung, kidney, and cervical cancers. It works by blocking the growth of new blood vessels that supply tumors with nutrients. This medication is often used in combination with other cancer treatments to improve outcomes.

Common effects of Avzivi may include high blood pressure, fatigue, and changes in appetite. Some patients may experience more severe side effects, such as bleeding or blood clots. It is important to discuss any unusual symptoms with a healthcare provider.

Avzivi should be administered under the supervision of a healthcare professional. Patients with a history of heart problems, high blood pressure, or bleeding disorders should use this medication with caution. Regular monitoring is essential to manage potential side effects.

Avzivi may interact with other medications, including blood thinners and certain cancer treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of Avzivi.